Healthpeak Properties, Inc.: Form 10-Q for the period ended Sep 30, 2020
Filed with the SEC on Nov 3, 2020 and accepted by EDGAR at Nov 3, 2020, 16:18 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-07-01 to 2020-09-30 | $264.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2020-01-01 to 2020-09-30 | $797.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2020-07-01 to 2020-09-30 | $314.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2020-01-01 to 2020-09-30 | $1.01bn | us-gaap:CostOfGoodsAndServicesSold |
| Interest expense | 3 months2020-07-01 to 2020-09-30 | $56.2m | us-gaap:InterestExpense |
| Interest expense | 9 months2020-01-01 to 2020-09-30 | $172.2m | us-gaap:InterestExpense |
| Income tax | 3 months2020-07-01 to 2020-09-30 | $24.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-01-01 to 2020-09-30 | −$16.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-07-01 to 2020-09-30 | −$63.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-01-01 to 2020-09-30 | $267.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-07-01 to 2020-09-30 | −$0.12 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2020-01-01 to 2020-09-30 | $0.50 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-07-01 to 2020-09-30 | −$0.12 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-01-01 to 2020-09-30 | $0.50 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-07-01 to 2020-09-30 | 538,333,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-01-01 to 2020-09-30 | 528,455,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-01-01 to 2020-09-30 | $539.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 9 months2020-01-01 to 2020-09-30 | $587.6m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2020-01-01 to 2020-09-30 | $10.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-09-30 | $197.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2020-09-30 | $15.75bn | us-gaap:Assets |
| Total liabilities | At period end2020-09-30 | $8.35bn | us-gaap:Liabilities |
| Long-term debt | At period end2020-09-30 | $6.46bn | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2020-09-30 | $6.84bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-20-015363. Last ingested by Listed: Nov 10, 2026, 05:05 ET. Listed shows no prices and gives no investment advice.